Evidence map›Paper›PMID 21490803›Full record

ArticleJournal of lipids2011

The Reorientation of T-Cell Polarity and Inhibition of Immunological Synapse Formation by CD46 Involves Its Recruitment to Lipid Rafts.

Mandy J Ludford-Menting, Blessing Crimeen-Irwin, Jane Oliaro, Anupama Pasam, David Williamson, Natalie Pedersen, Patricia Guillaumot, Dale Christansen, Serge Manie, Katharina Gaus and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipids, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Complement's favourite organelle-Mitochondria?British journal of pharmacology · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Complement as a regulator of adaptive immunity.Seminars in immunopathology · 2018
    Review
  8. Article
  9. Review
  10. Article
  11. Functional similarity analysis of human virus-encoded miRNAs.Journal of clinical bioinformatics · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Mandy J Ludford-MentingPeter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia.
Blessing Crimeen-Irwin
Jane Oliaro
Anupama Pasam
David Williamson
Natalie Pedersen
Patricia Guillaumot
Dale Christansen
Serge Manie
Katharina Gaus
Sarah M Russell
Peter MacCallum Cancer Centre · AUUniversity of Melbourne · AUCentre National de la Recherche Scientifique · FRUNSW Sydney · AU

Funding

Wellcome Trust
6 · The paper itself

Abstract

Many infectious agents utilize CD46 for infection of human cells, and therapeutic applications of CD46-binding viruses are now being explored. Besides mediating internalization to enable infection, binding to CD46 can directly alter immune function. In particular, ligation of CD46 by antibodies or by measles virus can prevent activation of T cells by altering T-cell polarity and consequently preventing the formation of an immunological synapse. Here, we define a mechanism by which CD46 reorients T-cell polarity to prevent T-cell receptor signaling in response to antigen presentation. We show that CD46 associates with lipid rafts upon ligation, and that this reduces recruitment of both lipid rafts and the microtubule organizing centre to the site of receptor cross-linking. These data combined indicate that polarization of T cells towards the site of CD46 ligation prevents formation of an immunological synapse, and this is associated with the ability of CD46 to recruit lipid rafts away from the site of TCR ligation.

Identifiers

PMID21490803
PMCPMC3067059
OpenAlexW1989071082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.